Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
Michael D FeherWilliam HintonAnna ForbesNeil MunroMark P JoyDavid Collins WheelerSimon de LusignanPublished in: JMIR research protocols (2022)
PRR1-10.2196/34206.